Molecular Improvement of Disease Resistance in Barley (MIDRIB)
Lead Participant:
LIMAGRAIN UK LIMITED
Abstract
Molecular Improvement of Disease Resistance in Barley (MIDRIB) describes the development and application of novel Genomic Selection technology for breeding new varieties. The primary aim is to develop new competitive varieties for the UK, with increased polygenic disease resistance, which will allow reductions in pesticide applications. The approach will develop innovative statistical models linking phenotypic data with high density molecular SNP marker analysis. The partners are Limagrain, NIAB, UCL and The James Hutton Institute. MIDRIB is a 5 year project.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| LIMAGRAIN UK LIMITED | £1,378,593 | £ 370,979 |
Participant |
||
| NIAB. | £85,341 | |
| NATIONAL INST OF AGRICULTURAL BOTANY | ||
| THE JAMES HUTTON INSTITUTE (FORMERLY KNOWN AS SCRI) | £71,996 | £ 71,996 |
| UNIVERSITY COLLEGE LONDON | ||
| UNIVERSITY COLLEGE LONDON | £454,633 | |
| JAMES HUTTON LIMITED |
People |
ORCID iD |
| Yannick Roux (Project Manager) |